Publications by authors named "Rachel M Shanahan"

Microbial populations have evolved intricate networks of negotiation and communication through which they can coexist in natural and host ecosystems. The nature of these systems can be complex and they are, for the most part, poorly understood at the polymicrobial level. The Pseudomonas Quinolone Signal (PQS) and its precursor 4-hydroxy-2-heptylquinoline (HHQ) are signal molecules produced by the important nosocomial pathogen .

View Article and Find Full Text PDF

Herein, we report a one-pot process that marries mechanistically distinct, traditional cross-coupling reactions with C-H functionalization using the same precatalyst. The reactions proceed in yields of up to 95%, in air, and require no extraneous ligand. The reactions are thought to be facilitated by harnessing the substrate quinoline as an -ligand, and evidence of the palladium-quinoline interaction is provided by H-N HMBC NMR spectroscopy and X-ray crystallographic structures.

View Article and Find Full Text PDF

A rapid decline in the development of new antimicrobial therapeutics has coincided with the emergence of new and more aggressive multidrug-resistant pathogens. Pathogens are protected from antibiotic activity by their ability to enter an aggregative biofilm state. Therefore, disrupting this process in pathogens is a key strategy for the development of next-generation antimicrobials.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Rachel M Shanahan"

  • - Rachel M Shanahan's research primarily focuses on understanding microbial communication and developing innovative strategies to combat multidrug-resistant pathogens through the chemical modification of signaling molecules.
  • - Her recent study on the structural modification of the alkylquinoline cell-cell communication signal (HHQ) highlighted the creation of benzofuranoquinolines that exhibit anti-virulence properties against ESKAPE pathogens, which are significant in nosocomial infections.
  • - Additionally, her work on small-molecule inhibitors against Candida albicans biofilm formation emphasizes the importance of disrupting biofilm resilience as a vital approach in the fight against antimicrobial resistance, underlining a significant gap in new antimicrobial therapies.